Definitive Healthcare CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Kevin Coop, CEO of Definitive Healthcare Corp., reported a transaction involving the withholding of shares to cover tax obligations.
NASDAQ
Definitive Healthcare Corp. Chief Legal Officer Jonathan Paris reported a transaction involving the withholding of shares to cover tax obligations.
NASDAQ
Director Samuel A. Hamood acquired 189,190 restricted stock units of Definitive Healthcare Corp. Class A Common Stock.
NASDAQ
Definitive Healthcare Corp. director Scott G. Stephenson was granted 189,190 restricted stock units as part of annual compensation.
NASDAQ
Definitive Healthcare Corp. director Kathleen A. Winters was granted 189,190 restricted stock units as part of annual equity compensation.
NASDAQ
Director Chilukuri Sastry acquired 189,190 shares of Class A Common Stock in Definitive Healthcare Corp. through restricted stock units.
NASDAQ
Kevin Coop, CEO of Definitive Healthcare Corp., acquired 66,050 shares of Class A Common Stock through a tax withholding transaction.
NASDAQ
Definitive Healthcare CEO Kevin Coop reported a transaction involving the sale of 37,593 shares of Class A Common Stock to cover tax obligations upon the vesting of Restricted Stock Units.
NASDAQ
Jason Krantz, Executive Chairman and 10% owner of Definitive Healthcare Corp., reported a transaction involving the withholding of shares for tax obligations.
NASDAQ
Definitive Healthcare Corp. CEO Kevin Coop disposed of 175,524 shares of Class A Common Stock for tax withholding obligations related to RSU vesting.
NASDAQ
Definitive Healthcare's EVP, Chief Data Officer Benjamin Graboske, was granted 631,068 restricted stock units, vesting over time.
NASDAQ
Definitive Healthcare's Chief Legal Officer, Jonathan Paris, was granted 481,505 restricted stock units, vesting over four years.
NASDAQ
Definitive Healthcare's Chief Financial Officer, Casey Heller, was granted 733,301 restricted stock units, vesting over approximately four years.
NASDAQ
Definitive Healthcare CEO Kevin Coop acquired over 1.7 million restricted stock units, increasing his direct beneficial ownership.
NASDAQ
Definitive Healthcare's Executive Chairman, Jason Ronald Krantz, acquired 242,719 restricted stock units set to vest in March 2027.
NASDAQ
Definitive Healthcare's Executive Chairman, Jason Krantz, disposed of 44,545 shares to cover tax obligations from restricted stock unit vesting.
NASDAQ
Definitive Healthcare CFO Casey Heller reported a tax-related disposition of 1,469 Class A Common Stock shares.
NASDAQ
Definitive Healthcare Corp.'s CFO, Casey Heller, was granted 195,313 restricted stock units, vesting over time subject to continued service.
NASDAQ
Definitive Healthcare CEO Kevin Coop disposed of 28,236 shares of Class A Common Stock to cover tax obligations related to restricted stock unit vesting.
NASDAQ
Definitive Healthcare's EVP, Chief Data Officer, Benjamin Graboske, disposed of 341,417 shares of Class A Common Stock to cover tax obligations related to accelerated RSU vesting.
NASDAQ
Definitive Healthcare's CFO, Casey Heller, disposed of 1,244 shares of Class A Common Stock to cover tax obligations related to RSU vesting.
NASDAQ
Definitive Healthcare Corp.'s Executive Chairman, Jason Ronald Krantz, reported a disposition of 18,796 Class A Common Stock shares at $2.77 per share to cover tax obligations related to restricted stock unit vesting.
NASDAQ
Definitive Healthcare's Chief Financial Officer, Casey Heller, disposed of 8,300 Class A Common Stock shares to satisfy tax obligations related to the vesting of restricted stock units.
NASDAQ
Definitive Healthcare Corp. CEO Kevin Coop reported a disposition of 37,593 Class A Common Stock shares for tax withholding purposes related to restricted stock unit vesting.
NASDAQ
Definitive Healthcare's Executive Chairman, Jason Krantz, reported a tax-related disposition of 4,093 Class A Common Stock shares.
NASDAQ
Definitive Healthcare's CFO, Casey Heller, reported a routine withholding of 1,244 Class A Common Stock shares for tax obligations related to RSU vesting.
NASDAQ
Definitive Healthcare Corp.'s COO, Kate Marie Shamsuddin, disposed of 4,741 shares of Class A Common Stock to cover tax liabilities from restricted stock unit vesting.
NASDAQ
Definitive Healthcare's Executive Chairman, Jason Krantz, reported a routine withholding of shares for tax obligations related to restricted stock unit vesting.
NASDAQ
Definitive Healthcare Corp.'s CEO and Director, Kevin Coop, disposed of 116,750 shares of Class A Common Stock on July 1, 2025, to cover tax withholding obligations related to restricted stock unit vesting.
NASDAQ
Jonathan Paris, Chief Legal Officer of Definitive Healthcare Corp., has been granted 421,349 restricted stock units, aligning his interests with long-term company performance.